| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/26/2009 | US20090082365 Trisubstituted Quinazolinone Derivatives as Vanilloid Antagonists |
| 03/26/2009 | US20090082362 Use of capsaicin receptor antagonists to treat symptoms of tear gas exposure |
| 03/26/2009 | US20090082359 5-pyridinone substituted indazoles |
| 03/26/2009 | US20090082343 1,3-benzothiazinone derivatives and use thereof |
| 03/26/2009 | US20090082330 Certain substituted amides, method of making, and method of use thereof |
| 03/26/2009 | US20090082329 Novel Sulphur-Containing Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors |
| 03/26/2009 | US20090081165 Bicyclic heteroaryl derivatives |
| 03/26/2009 | US20090079343 Organic electroluminescent device |
| 03/26/2009 | CA2700051A1 Small molecule bradykinin b1 receptor antagonists |
| 03/26/2009 | CA2699989A1 N-phenyl-dioxo-hydro pyrimidines useful as hepatitis c virus (hcv) inhibitor |
| 03/26/2009 | CA2699986A1 Anti-infective pyrimidines and uses thereof |
| 03/26/2009 | CA2699981A1 Uracil or thymine derivative for treating hepatitis c |
| 03/26/2009 | CA2699849A1 Inhibitors of the interaction between mdm2 and p53 |
| 03/26/2009 | CA2699689A1 Substituted nicotinamide compounds and their use in medicaments |
| 03/26/2009 | CA2699417A1 S1p receptor modulating compounds and use thereof |
| 03/26/2009 | CA2698527A1 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists |
| 03/26/2009 | CA2697551A1 Piperidine derivatives as modulators of gpr119 activity |
| 03/26/2009 | CA2696508A1 Diacylglycerol acyltransferase inhibitors |
| 03/26/2009 | CA2691474A1 Cyanoisoquinoline |
| 03/26/2009 | CA2691031A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides |
| 03/25/2009 | EP2039694A1 CGRP receptor antagonists |
| 03/25/2009 | EP2039687A1 Therapeutic or prophylactic agent for multiple sclerosis |
| 03/25/2009 | EP2039685A2 Heterobicyclic compounds as P38 inhibitors |
| 03/25/2009 | EP2039683A2 Vasculostatic agents and methods of use thereof |
| 03/25/2009 | EP2038272A2 Pyridinonyl pdk1 inhibitors |
| 03/25/2009 | EP2038271A1 Process for the preparation of optically pure or optically enriched enantiomers of sulphoxide compounds |
| 03/25/2009 | EP2038264A1 Tetrazole-substituted arylamides |
| 03/25/2009 | EP2038262A2 Triazole compounds that modulate hsp90 activity |
| 03/25/2009 | EP2038261A2 Pyrazine derivatives with extended conjugation and uses thereof |
| 03/25/2009 | EP2038257A1 N-oxides of diarylurea derivatives and their use as chk1 inhibitors for the treatment of cancer |
| 03/25/2009 | EP2038254A2 Bicyclic compositions and methods for modulating a kinase cascade |
| 03/25/2009 | EP2037930A1 The use of 1,4-diaryl-dihydropyrimidine-2-on derivatives for treating pulmonary arterial hypertension |
| 03/25/2009 | EP2037741A1 Compositions and methods relating to novel compounds and targets thereof |
| 03/25/2009 | EP2037739A2 Benzyl-substituted quinolone m1 receptor positive allosteric modulators |
| 03/25/2009 | EP2000469A9 Acylaminopiperidine compound |
| 03/25/2009 | EP2000463A9 Nitrogen-containing heterocyclic derivative and organic electroluminescent device using same |
| 03/25/2009 | EP1756063A4 Amido compounds and their use as pharmaceuticals |
| 03/25/2009 | CN101395157A Pyrrazole derivatives as sigma receptors antagonists |
| 03/25/2009 | CN101395150A Phenethanolamine derivatives as beta2 adrenoreceptor agonists |
| 03/25/2009 | CN101395149A New amines |
| 03/25/2009 | CN101395148A N-formyl hydroxylamine compounds |
| 03/25/2009 | CN101395135A New primary amines |
| 03/25/2009 | CN101395133A Sigma receptor compounds |
| 03/25/2009 | CN101394849A Stable dosage formulations of imidazolylalkyl-pyridines |
| 03/25/2009 | CN101394742A Anthranilamide derivatives and their use for the control of insects and acari |
| 03/25/2009 | CN101391993A Method for preparing S-omeprazole and salt thereof by forming inclusion complex with (S)-(-)-1,1'-dinaphthalene-2,2'-diol |
| 03/25/2009 | CN101391976A Process for the preparation of N-amino substituted heterocyclic compounds |
| 03/25/2009 | CN100471856C Bicyclic compounds and compostions as PDF inhibitors |
| 03/25/2009 | CN100471854C Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 03/25/2009 | CN100471842C Quinolone derivative or its salt |
| 03/25/2009 | CN100471838C VLA-4 inhibitors |
| 03/24/2009 | US7507836 Benzamide modulators of metabotropic glutamate receptors |
| 03/24/2009 | US7507829 Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
| 03/24/2009 | US7507825 Condensation of 7-ethyl-10-hydroxycamptothecin with 1-chlorocarbonyl-4-piperidinopiperidine hydrochloride in a polar aprotic solvent in the presence of 4-dimethylaminopyridine; topoisomerase inhibitor which is used in treatment of lung and rectum cancer |
| 03/24/2009 | US7507815 Succinoylamino lactams as inhibitors of a-β protein production |
| 03/24/2009 | US7507760 Strokes, hypotensive agents, antidepressants,central nervous system disorders, psychological disorders, schizophrenia, alcoholism, drug abuse |
| 03/24/2009 | US7507756 (2-Chlorophenyl)-[2-(1-isopropyl-piperidin-4-ylmethoxy)-3-methyl-3H-imidazol-4-yl]-]-methanone; histamine receptor antagonist; neurologic disorders; reacting imidazole compound with base and perhaloalkane, to form 2-haloimidazole, and with electrophile to form C-5 position substituted imidazole compound |
| 03/24/2009 | US7507753 Biaryl compound and use thereof |
| 03/24/2009 | US7507751 Biphenyl derivatives |
| 03/24/2009 | US7507748 e.g. 2-(7-isoquinolinylamino)-N-(3-methyl-4-(1-methylethyl)phenyl)-3-pyridinecarboxamide; Vascular Endothelial Growth Factor antagonist; angiogenesis inhibitor; anticarcinogenic, antiinflammatory inhibitor; retinopathies, rheumatoid arthritis, asthma, atherosclerosis, endometriosis, neoplastic diseases |
| 03/24/2009 | US7507747 Muscarinic acetylcholine receptor antagonists |
| 03/24/2009 | US7507738 Intermediates to anticancer agents, NK1 antagonists, or elastase inhibitors; 2-(alkoxy, aryl, alkyl, alkylamino or alkylthio)-6-oxo-5-(protected amino)-1,6-dihydropyrimidine by reacting an N-protected glycine ester with dimethylformamidedimethylacetal, reacting with acid and then amidine compound |
| 03/24/2009 | US7507737 Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4receptor |
| 03/24/2009 | US7507736 Indol-2-yl-piperazin-1-yl-methanone derivatives |
| 03/24/2009 | US7507735 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 4-[(3-fluoro-5-{[(6-methyl(3-pyridyl))amino]carbonylamino}-phenyl)methyl]piperazinecarboxylate |
| 03/24/2009 | US7507734 Pyridazinone derivatives |
| 03/24/2009 | US7507733 11b-HSD1 inhibitors for the treatment of diabetes |
| 03/24/2009 | US7507732 6,7-Dihydro-5H-cyclopenta[b]pyridine and 5,6,7,8-tetrahydroquinoline compounds; 5-HT2c receptor agonists; to treat diseases like obesity, depression, atypical depression, anxiety, epilepsy, lower urinary tract dysfunction; less toxic; selectivity |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/24/2009 | CA2390558C Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and agents containing the same |
| 03/24/2009 | CA2342616C Method of treating a textile |
| 03/24/2009 | CA2289492C Synthesis of acridine derivative multidrug-resistant inhibitors |
| 03/24/2009 | CA2224060C Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 03/19/2009 | WO2009036144A1 Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists |
| 03/19/2009 | WO2009036117A1 Azacyclylisoquinolinone and isoindolinone derivatives as histamine-3 antagonists |
| 03/19/2009 | WO2009035068A1 Novel 1,3,3-trimethyl-7-phenyl-3,4-dihydro-1h-quinoxalin- 2-one derivatives |
| 03/19/2009 | WO2009035067A1 Glucocorticoid receptor agonists consisting of 1,3,3-tri- methyl-7-phenyl-3,4-dihydro-1h-quinoxalin-2-one derivatives |
| 03/19/2009 | WO2009034581A1 Substituted indolyl compounds and their use as 5-ht6 ligands |
| 03/19/2009 | WO2009034388A1 Compounds for the treatment of metabolic disorders |
| 03/19/2009 | WO2009034380A1 Piperidine derivatives as agonists of muscarinic receptors |
| 03/19/2009 | WO2009034062A1 Compounds which inhibit the glycine transporter and uses thereof in medicine |
| 03/19/2009 | WO2009034061A1 Spiro-condensed imidazolone derivatives inhibiting the glycine transporter |
| 03/19/2009 | WO2009034029A2 1-substituted 4-heterocyclylpiperidines for use as cgrp antagonists |
| 03/19/2009 | WO2009033995A1 Piperidine derivatives as nk3 receptor antagonists |
| 03/19/2009 | WO2009033704A1 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1, 4'] bipyridinyl-2'-ones |
| 03/19/2009 | WO2009033702A1 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
| 03/19/2009 | WO2009023539A3 Tetrahydropyridine carboxamide derivatives as trpvl antagonists |
| 03/19/2009 | WO2009014637A3 Heterocyclic amide compounds as protein kinase inhibitors |
| 03/19/2009 | WO2009013299A3 Novel bradykinin b1 antagonists |
| 03/19/2009 | WO2009008913A3 P1-nonepimerizable ketoamide inhibitors of hcv ns3 protease |
| 03/19/2009 | WO2009007536A3 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 03/19/2009 | WO2009007390A3 2-pyraz inylbenz imidazole derivatives as receptor tyrosine kinase inhibitors |
| 03/19/2009 | WO2009006567A3 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 03/19/2009 | WO2009005646A3 Substituted piperazines as cb1 antagonists |
| 03/19/2009 | WO2008147626A3 Thiazoles and pyrazoles useful as kinase inhibitors |
| 03/19/2009 | WO2008137619A3 Thiazoles and pyrazoles useful as kinase inhibitors |
| 03/19/2009 | US20090076277 Process for the preparation of pyridine-methylsulfinyl compounds |
| 03/19/2009 | US20090076276 such as (R)-3-(3-hydroxypyrrolidin-1-yl)-N-methyl-N-methoxypropanamide; poly(ADP-ribose)polymerase inhibitors |
| 03/19/2009 | US20090076272 Polymorphs of eszopiclone malate |
| 03/19/2009 | US20090076089 Deuterium-enriched pantoprazole |